SWITCH THERAPEUTICS INC.

Profile

Company Names

SWITCH THERAPEUTICS INC.

Addresses

241 E HARRIS AVE, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(415) 518-9678

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$23,270,993.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-09-27 
$23,270,993.00 
$35,984,988.00 
$12,713,995.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DEEPSHIKHA 
 
DATTA 
EXECUTIVE OFFICER, DIRECTOR
SWITCH THERAPEUTICS INC.
SI-PING 
 
HAN 
EXECUTIVE OFFICER
SWITCH THERAPEUTICS INC.
ALICIA 
 
IRURZUN-LAFITTE 
DIRECTOR
SWITCH THERAPEUTICS INC.
DYLAN 
 
MORRIS 
DIRECTOR
INTEGRATED PLASMONICS CORP   |  DECIDUOUS THERAPEUTICS, INC.   |  UNLEARN.AI, INC.   |  GAMETO, INC.   |  PROFLUENT BIO INC.   |  SWITCH THERAPEUTICS INC.   |  IMMUNEBRIDGE INC.   |  CAPACITY BIO, INC.   |  SUPERLUMINAL MEDICINES, INC.   |  EXSILIO THERAPEUTICS INC.   |  AVERNA THERAPEUTICS INC.
KEVIN 
 
ZHANG 
DIRECTOR
APPCONOMY, INC.   |  BAD PANDA, INC.   |  IDELIC INC.   |  STRAY BOMBAY CO   |  GAMMA LABS, INC.   |  HEALTH DATA VISION, INC.   |  STRIMMERZ MEDIA, INC.   |  AGORA HEALTH INC.   |  SWITCH THERAPEUTICS INC.   |  CELLULAR LONGEVITY, INC.   |  RELAY FINANCIAL TECHNOLOGIES INC.   |  PLAYBOOK DIGITAL INC.   |  DAYTONA PLATFORMS INC.   |  UPFRONT SECONDARY V, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-11-17
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-27 
2022-10-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#